Lauren Stentz, Oncology Roundtable
Physicians should find significantly more polyps during screening colonoscopies than national benchmarks suggest, according to a recent Mayo Clinic study. With the increasing prevalence of high-definition colonoscopy technology, Mayo researchers believe that national standards need to be reevaluated.
Mayo study suggests higher benchmarks needed in colorectal screening
Our colleagues at the Imaging Performance Partnership recently posted an article summarizing the results of a Journal of Medical Screening review of European studies on service screening for breast cancer.
Researchers uncovered a significant mortality benefit from screening, upending skeptical studies and reports published over the past few months.
In case you didn’t see the article, we've reposted it below.
In case you missed it: European breast cancer study finds substantial screening benefits
My colleague Nicholas Bartz from the Imaging Performance Partnership recently wrote a nice summary and analysis of the results from the NCI's National Lung Screening Trial, and I wanted to pass it along:
In October 2010 the National Cancer Institute announced a premature end to its National Lung Screening Trial after finding that low-dose CT screening of high-risk participants was associated with a 20 percent mortality reduction. Now, as the first formal report of that trial appears in the New England Journal of Medicine, both the trial's researchers and outside parties are raising questions as to whether CT lung screening is ready to be implemented on a broad scale.
Success of Lung Screening Trial Raises New Questions